Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A "glyconutrient sham".

Ronald L Schnaar1, Hudson H Freeze

  • 1Department of Pharmacology and Molecular Sciences, The Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. schnaar@jhu.edu

Glycobiology
|September 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALG14 Variants Contribute to a Congenital Disorder of Glycosylation Characterized by Congenital Myasthenia and Epilepsy.

HGG advances·2026
Same author

Predictions from deep learning propose substantial protein-carbohydrate interplay.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Patient iPSC-Derived Cartilage Organoids Reveal Defective ECM Deposition and Altered Chondrogenic Trajectory in Saul-Wilson Syndrome.

bioRxiv : the preprint server for biology·2026
Same author

Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation.

Science advances·2026
Same author

A homozygous nonsense variant in the oligosaccharyltransferase complex gene, RPN1, causes a congenital disorder of glycosylation.

HGG advances·2026
Same author

Gangliosides in molecular interactions and cell regulation.

The Journal of biological chemistry·2026

Glycobiology research is exploited by the glyconutrient industry, which markets plant extracts using scientific findings. This industry

Area of Science:

  • * Glycobiology: The scientific study of carbohydrates (sugars) and their roles in biological systems.
  • * Nutraceuticals: Focus on the intersection of carbohydrate science and commercial health products.

Background:

  • * Glycobiology is a vital scientific field contributing to understanding human health and disease.
  • * Legitimate glycobiology discoveries are being leveraged for commercial purposes.
  • * The glyconutrient industry is a significant global market, generating substantial annual revenue.

Purpose of the Study:

  • * To clarify the relationship between the scientific discipline of glycobiology and the commercial products termed 'glyconutrients'.
  • * To examine the potential impact of glyconutrient marketing claims on the public and the scientific community.

Main Methods:

  • * Literature review and analysis of scientific publications in glycobiology.

Related Experiment Videos

  • * Examination of marketing materials and industry practices related to glyconutrients.
  • * Assessment of the scientific validity of claims made by the glyconutrient industry.

    • Main Results:

    • * A significant disconnect exists between rigorous scientific research in glycobiology and the claims made by glyconutrient marketers.
    • * The glyconutrient industry utilizes scientific terminology and findings to promote products with unsubstantiated health benefits.
    • * The global market for glyconutrients is substantial, indicating widespread public engagement with these products.

    Conclusions:

    • * The commercial exploitation of glycobiology research by the glyconutrient industry raises concerns about scientific integrity and public understanding.
    • * There is a need for clearer communication and regulation to distinguish between scientific evidence and marketing claims in the area of glyconutrients.
    • * The public and the scientific discipline of glycobiology may be negatively impacted by misleading claims and the commercialization of scientific discoveries.